Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

15-Lipoxygenase-1 as a tumor suppressor gene in colon cancer: is the verdict in?

Il Lee S, Zuo X, Shureiqi I.

Cancer Metastasis Rev. 2011 Dec;30(3-4):481-91. doi: 10.1007/s10555-011-9321-0. Review.

PMID:
22037943
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Mechanistic contribution of ubiquitous 15-lipoxygenase-1 expression loss in cancer cells to terminal cell differentiation evasion.

Moussalli MJ, Wu Y, Zuo X, Yang XL, Wistuba II, Raso MG, Morris JS, Bowser JL, Minna JD, Lotan R, Shureiqi I.

Cancer Prev Res (Phila). 2011 Dec;4(12):1961-72. doi: 10.1158/1940-6207.CAPR-10-0280. Epub 2011 Aug 31.

PMID:
21881028
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Interpreting clinical assays for histone deacetylase inhibitors.

Martinet N, Bertrand P.

Cancer Manag Res. 2011;3:117-41. doi: 10.2147/CMR.S9661. Epub 2011 May 9.

PMID:
21625397
[PubMed]
Free PMC Article
4.

New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer.

Cang S, Ma Y, Liu D.

J Hematol Oncol. 2009 Jun 1;2:22. doi: 10.1186/1756-8722-2-22. Review.

PMID:
19486511
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

The chemical chaperone 4-phenylbutyrate inhibits adipogenesis by modulating the unfolded protein response.

Basseri S, Lhoták S, Sharma AM, Austin RC.

J Lipid Res. 2009 Dec;50(12):2486-501. doi: 10.1194/jlr.M900216-JLR200.

PMID:
19461119
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk